Global Genome Engineering Editing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Genome Engineering Editing market size was valued at US$ 7276 million in 2024 and is forecast to a readjusted size of USD 23280 million by 2031 with a CAGR of 18.0% during review period.
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report is a detailed and comprehensive analysis for global Genome Engineering Editing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genome Engineering Editing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genome Engineering Editing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon?Horizo??n Discovery?, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genome Engineering Editing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genome Engineering Editing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genome Engineering Editing, with revenue, gross margin, and global market share of Genome Engineering Editing from 2020 to 2025.
Chapter 3, the Genome Engineering Editing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Genome Engineering Editing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genome Engineering Editing.
Chapter 13, to describe Genome Engineering Editing research findings and conclusion.
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
Global key players of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, etc. The top five players hold a share over 52%. North America is the largest market, and has a share about 37%, followed by Asia-Pacific and Europe with share 25% and 18%, separately. In terms of product type, CRISPR RNP is the largest segment, occupied for a share of 39%. In terms of application, GMP has a share about 70 percent.
This report is a detailed and comprehensive analysis for global Genome Engineering Editing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genome Engineering Editing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Genome Engineering Editing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genome Engineering Editing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genome Engineering Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon?Horizo??n Discovery?, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genome Engineering Editing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CRISPR RNP
- CRISPR mRNA
- CRISPR Virus Delivery
- Others
- RUO
- GMP
- Thermo Fisher Scientific
- SIGMA ALDRICH
- Dharmacon?Horizo??n Discovery?
- Cellectics
- CRISPR Therapeutics
- AstraZeneca
- Bio Rad
- Allele Biotech
- Recombinetics
- Lonza
- Illumina
- Editas Medicine
- Agilent Technologies
- QIAGEN NV
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genome Engineering Editing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genome Engineering Editing, with revenue, gross margin, and global market share of Genome Engineering Editing from 2020 to 2025.
Chapter 3, the Genome Engineering Editing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Genome Engineering Editing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genome Engineering Editing.
Chapter 13, to describe Genome Engineering Editing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genome Engineering Editing by Type
1.3.1 Overview: Global Genome Engineering Editing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Genome Engineering Editing Consumption Value Market Share by Type in 2024
1.3.3 CRISPR RNP
1.3.4 CRISPR mRNA
1.3.5 CRISPR Virus Delivery
1.3.6 Others
1.4 Global Genome Engineering Editing Market by Application
1.4.1 Overview: Global Genome Engineering Editing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 RUO
1.4.3 GMP
1.5 Global Genome Engineering Editing Market Size & Forecast
1.6 Global Genome Engineering Editing Market Size and Forecast by Region
1.6.1 Global Genome Engineering Editing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Genome Engineering Editing Market Size by Region, (2020-2031)
1.6.3 North America Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.4 Europe Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.6 South America Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Genome Engineering Editing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Engineering Editing Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 SIGMA ALDRICH
2.2.1 SIGMA ALDRICH Details
2.2.2 SIGMA ALDRICH Major Business
2.2.3 SIGMA ALDRICH Genome Engineering Editing Product and Solutions
2.2.4 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 SIGMA ALDRICH Recent Developments and Future Plans
2.3 Dharmacon?Horizo??n Discovery?
2.3.1 Dharmacon?Horizo??n Discovery? Details
2.3.2 Dharmacon?Horizo??n Discovery? Major Business
2.3.3 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Solutions
2.3.4 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Dharmacon?Horizo??n Discovery? Recent Developments and Future Plans
2.4 Cellectics
2.4.1 Cellectics Details
2.4.2 Cellectics Major Business
2.4.3 Cellectics Genome Engineering Editing Product and Solutions
2.4.4 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cellectics Recent Developments and Future Plans
2.5 CRISPR Therapeutics
2.5.1 CRISPR Therapeutics Details
2.5.2 CRISPR Therapeutics Major Business
2.5.3 CRISPR Therapeutics Genome Engineering Editing Product and Solutions
2.5.4 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 CRISPR Therapeutics Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Genome Engineering Editing Product and Solutions
2.6.4 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Bio Rad
2.7.1 Bio Rad Details
2.7.2 Bio Rad Major Business
2.7.3 Bio Rad Genome Engineering Editing Product and Solutions
2.7.4 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Bio Rad Recent Developments and Future Plans
2.8 Allele Biotech
2.8.1 Allele Biotech Details
2.8.2 Allele Biotech Major Business
2.8.3 Allele Biotech Genome Engineering Editing Product and Solutions
2.8.4 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Allele Biotech Recent Developments and Future Plans
2.9 Recombinetics
2.9.1 Recombinetics Details
2.9.2 Recombinetics Major Business
2.9.3 Recombinetics Genome Engineering Editing Product and Solutions
2.9.4 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Recombinetics Recent Developments and Future Plans
2.10 Lonza
2.10.1 Lonza Details
2.10.2 Lonza Major Business
2.10.3 Lonza Genome Engineering Editing Product and Solutions
2.10.4 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Lonza Recent Developments and Future Plans
2.11 Illumina
2.11.1 Illumina Details
2.11.2 Illumina Major Business
2.11.3 Illumina Genome Engineering Editing Product and Solutions
2.11.4 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Illumina Recent Developments and Future Plans
2.12 Editas Medicine
2.12.1 Editas Medicine Details
2.12.2 Editas Medicine Major Business
2.12.3 Editas Medicine Genome Engineering Editing Product and Solutions
2.12.4 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Editas Medicine Recent Developments and Future Plans
2.13 Agilent Technologies
2.13.1 Agilent Technologies Details
2.13.2 Agilent Technologies Major Business
2.13.3 Agilent Technologies Genome Engineering Editing Product and Solutions
2.13.4 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Agilent Technologies Recent Developments and Future Plans
2.14 QIAGEN NV
2.14.1 QIAGEN NV Details
2.14.2 QIAGEN NV Major Business
2.14.3 QIAGEN NV Genome Engineering Editing Product and Solutions
2.14.4 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 QIAGEN NV Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genome Engineering Editing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Genome Engineering Editing by Company Revenue
3.2.2 Top 3 Genome Engineering Editing Players Market Share in 2024
3.2.3 Top 6 Genome Engineering Editing Players Market Share in 2024
3.3 Genome Engineering Editing Market: Overall Company Footprint Analysis
3.3.1 Genome Engineering Editing Market: Region Footprint
3.3.2 Genome Engineering Editing Market: Company Product Type Footprint
3.3.3 Genome Engineering Editing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genome Engineering Editing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Genome Engineering Editing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genome Engineering Editing Consumption Value Market Share by Application (2020-2025)
5.2 Global Genome Engineering Editing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Genome Engineering Editing Consumption Value by Type (2020-2031)
6.2 North America Genome Engineering Editing Market Size by Application (2020-2031)
6.3 North America Genome Engineering Editing Market Size by Country
6.3.1 North America Genome Engineering Editing Consumption Value by Country (2020-2031)
6.3.2 United States Genome Engineering Editing Market Size and Forecast (2020-2031)
6.3.3 Canada Genome Engineering Editing Market Size and Forecast (2020-2031)
6.3.4 Mexico Genome Engineering Editing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Genome Engineering Editing Consumption Value by Type (2020-2031)
7.2 Europe Genome Engineering Editing Consumption Value by Application (2020-2031)
7.3 Europe Genome Engineering Editing Market Size by Country
7.3.1 Europe Genome Engineering Editing Consumption Value by Country (2020-2031)
7.3.2 Germany Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.3 France Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.5 Russia Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.6 Italy Genome Engineering Editing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genome Engineering Editing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Genome Engineering Editing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Genome Engineering Editing Market Size by Region
8.3.1 Asia-Pacific Genome Engineering Editing Consumption Value by Region (2020-2031)
8.3.2 China Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.3 Japan Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.4 South Korea Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.5 India Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.7 Australia Genome Engineering Editing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Genome Engineering Editing Consumption Value by Type (2020-2031)
9.2 South America Genome Engineering Editing Consumption Value by Application (2020-2031)
9.3 South America Genome Engineering Editing Market Size by Country
9.3.1 South America Genome Engineering Editing Consumption Value by Country (2020-2031)
9.3.2 Brazil Genome Engineering Editing Market Size and Forecast (2020-2031)
9.3.3 Argentina Genome Engineering Editing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genome Engineering Editing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Genome Engineering Editing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Genome Engineering Editing Market Size by Country
10.3.1 Middle East & Africa Genome Engineering Editing Consumption Value by Country (2020-2031)
10.3.2 Turkey Genome Engineering Editing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Genome Engineering Editing Market Size and Forecast (2020-2031)
10.3.4 UAE Genome Engineering Editing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Genome Engineering Editing Market Drivers
11.2 Genome Engineering Editing Market Restraints
11.3 Genome Engineering Editing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genome Engineering Editing Industry Chain
12.2 Genome Engineering Editing Upstream Analysis
12.3 Genome Engineering Editing Midstream Analysis
12.4 Genome Engineering Editing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Genome Engineering Editing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Genome Engineering Editing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Genome Engineering Editing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Genome Engineering Editing Consumption Value by Region (2026-2031) & (USD Million)
Table 5.ThermoFisher Scientific Company Information, Head Office, and Major Competitors
Table 6.ThermoFisher Scientific Major Business
Table 7.ThermoFisher Scientific Genome Engineering Editing Product and Solutions
Table 8.ThermoFisher Scientific Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9.ThermoFisher Scientific Recent Developments andFuture Plans
Table 10. SIGMA ALDRICH Company Information, Head Office, and Major Competitors
Table 11. SIGMA ALDRICH Major Business
Table 12. SIGMA ALDRICH Genome Engineering Editing Product and Solutions
Table 13. SIGMA ALDRICH Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. SIGMA ALDRICH Recent Developments andFuture Plans
Table 15. Dharmacon?Horizo??n Discovery? Company Information, Head Office, and Major Competitors
Table 16. Dharmacon?Horizo??n Discovery? Major Business
Table 17. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Solutions
Table 18. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Cellectics Company Information, Head Office, and Major Competitors
Table 20. Cellectics Major Business
Table 21. Cellectics Genome Engineering Editing Product and Solutions
Table 22. Cellectics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Cellectics Recent Developments andFuture Plans
Table 24. CRISPRTherapeutics Company Information, Head Office, and Major Competitors
Table 25. CRISPRTherapeutics Major Business
Table 26. CRISPRTherapeutics Genome Engineering Editing Product and Solutions
Table 27. CRISPRTherapeutics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. CRISPRTherapeutics Recent Developments andFuture Plans
Table 29. AstraZeneca Company Information, Head Office, and Major Competitors
Table 30. AstraZeneca Major Business
Table 31. AstraZeneca Genome Engineering Editing Product and Solutions
Table 32. AstraZeneca Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. AstraZeneca Recent Developments andFuture Plans
Table 34. Bio Rad Company Information, Head Office, and Major Competitors
Table 35. Bio Rad Major Business
Table 36. Bio Rad Genome Engineering Editing Product and Solutions
Table 37. Bio Rad Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Bio Rad Recent Developments andFuture Plans
Table 39. Allele Biotech Company Information, Head Office, and Major Competitors
Table 40. Allele Biotech Major Business
Table 41. Allele Biotech Genome Engineering Editing Product and Solutions
Table 42. Allele Biotech Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Allele Biotech Recent Developments andFuture Plans
Table 44. Recombinetics Company Information, Head Office, and Major Competitors
Table 45. Recombinetics Major Business
Table 46. Recombinetics Genome Engineering Editing Product and Solutions
Table 47. Recombinetics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Recombinetics Recent Developments andFuture Plans
Table 49. Lonza Company Information, Head Office, and Major Competitors
Table 50. Lonza Major Business
Table 51. Lonza Genome Engineering Editing Product and Solutions
Table 52. Lonza Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Lonza Recent Developments andFuture Plans
Table 54. Illumina Company Information, Head Office, and Major Competitors
Table 55. Illumina Major Business
Table 56. Illumina Genome Engineering Editing Product and Solutions
Table 57. Illumina Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Illumina Recent Developments andFuture Plans
Table 59. Editas Medicine Company Information, Head Office, and Major Competitors
Table 60. Editas Medicine Major Business
Table 61. Editas Medicine Genome Engineering Editing Product and Solutions
Table 62. Editas Medicine Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Editas Medicine Recent Developments andFuture Plans
Table 64. AgilentTechnologies Company Information, Head Office, and Major Competitors
Table 65. AgilentTechnologies Major Business
Table 66. AgilentTechnologies Genome Engineering Editing Product and Solutions
Table 67. AgilentTechnologies Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. AgilentTechnologies Recent Developments andFuture Plans
Table 69. QIAGEN NV Company Information, Head Office, and Major Competitors
Table 70. QIAGEN NV Major Business
Table 71. QIAGEN NV Genome Engineering Editing Product and Solutions
Table 72. QIAGEN NV Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. QIAGEN NV Recent Developments andFuture Plans
Table 74. Global Genome Engineering Editing Revenue (USD Million) by Players (2020-2025)
Table 75. Global Genome Engineering Editing Revenue Share by Players (2020-2025)
Table 76. Breakdown of Genome Engineering Editing by CompanyType (Tier 1,Tier 2, andTier 3)
Table 77. Market Position of Players in Genome Engineering Editing, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 78. Head Office of Key Genome Engineering Editing Players
Table 79. Genome Engineering Editing Market: Company ProductTypeFootprint
Table 80. Genome Engineering Editing Market: Company Product ApplicationFootprint
Table 81. Genome Engineering Editing New Market Entrants and Barriers to Market Entry
Table 82. Genome Engineering Editing Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Genome Engineering Editing Consumption Value (USD Million) byType (2020-2025)
Table 84. Global Genome Engineering Editing Consumption Value Share byType (2020-2025)
Table 85. Global Genome Engineering Editing Consumption ValueForecast byType (2026-2031)
Table 86. Global Genome Engineering Editing Consumption Value by Application (2020-2025)
Table 87. Global Genome Engineering Editing Consumption ValueForecast by Application (2026-2031)
Table 88. North America Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 89. North America Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 90. North America Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 95. Europe Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 96. Europe Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 101. Asia-Pacific Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 102. Asia-Pacific Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Genome Engineering Editing Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Genome Engineering Editing Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 107. South America Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 108. South America Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 113. Middle East & Africa Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 114. Middle East & Africa Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Genome Engineering Editing Upstream (Raw Materials)
Table 119. Global Genome Engineering EditingTypical Customers
LIST OFFIGURES
Figure 1. Genome Engineering Editing Picture
Figure 2. Global Genome Engineering Editing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Genome Engineering Editing Consumption Value Market Share byType in 2024
Figure 4. CRISPR RNP
Figure 5. CRISPR mRNA
Figure 6. CRISPR Virus Delivery
Figure 7. Others
Figure 8. Global Genome Engineering Editing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Genome Engineering Editing Consumption Value Market Share by Application in 2024
Figure 10. RUO Picture
Figure 11. GMP Picture
Figure 12. Global Genome Engineering Editing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Genome Engineering Editing Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Market Genome Engineering Editing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Genome Engineering Editing Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Genome Engineering Editing Consumption Value Market Share by Region in 2024
Figure 17. North America Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 22. CompanyThree Recent Developments andFuture Plans
Figure 23. Global Genome Engineering Editing Revenue Share by Players in 2024
Figure 24. Genome Engineering Editing Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 25. Market Share of Genome Engineering Editing by Player Revenue in 2024
Figure 26.Top 3 Genome Engineering Editing Players Market Share in 2024
Figure 27.Top 6 Genome Engineering Editing Players Market Share in 2024
Figure 28. Global Genome Engineering Editing Consumption Value Share byType (2020-2025)
Figure 29. Global Genome Engineering Editing Market ShareForecast byType (2026-2031)
Figure 30. Global Genome Engineering Editing Consumption Value Share by Application (2020-2025)
Figure 31. Global Genome Engineering Editing Market ShareForecast by Application (2026-2031)
Figure 32. North America Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 33. North America Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 39. Europe Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 42.France Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 47. Asia-Pacific Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Genome Engineering Editing Consumption Value Market Share by Region (2020-2031)
Figure 49. China Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 52. India Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 56. South America Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 61. Middle East & Africa Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 63.Turkey Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 66. Genome Engineering Editing Market Drivers
Figure 67. Genome Engineering Editing Market Restraints
Figure 68. Genome Engineering Editing MarketTrends
Figure 69. PortersFiveForces Analysis
Figure 70. Genome Engineering Editing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genome Engineering Editing by Type
1.3.1 Overview: Global Genome Engineering Editing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Genome Engineering Editing Consumption Value Market Share by Type in 2024
1.3.3 CRISPR RNP
1.3.4 CRISPR mRNA
1.3.5 CRISPR Virus Delivery
1.3.6 Others
1.4 Global Genome Engineering Editing Market by Application
1.4.1 Overview: Global Genome Engineering Editing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 RUO
1.4.3 GMP
1.5 Global Genome Engineering Editing Market Size & Forecast
1.6 Global Genome Engineering Editing Market Size and Forecast by Region
1.6.1 Global Genome Engineering Editing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Genome Engineering Editing Market Size by Region, (2020-2031)
1.6.3 North America Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.4 Europe Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.6 South America Genome Engineering Editing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Genome Engineering Editing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genome Engineering Editing Product and Solutions
2.1.4 Thermo Fisher Scientific Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 SIGMA ALDRICH
2.2.1 SIGMA ALDRICH Details
2.2.2 SIGMA ALDRICH Major Business
2.2.3 SIGMA ALDRICH Genome Engineering Editing Product and Solutions
2.2.4 SIGMA ALDRICH Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 SIGMA ALDRICH Recent Developments and Future Plans
2.3 Dharmacon?Horizo??n Discovery?
2.3.1 Dharmacon?Horizo??n Discovery? Details
2.3.2 Dharmacon?Horizo??n Discovery? Major Business
2.3.3 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Solutions
2.3.4 Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Dharmacon?Horizo??n Discovery? Recent Developments and Future Plans
2.4 Cellectics
2.4.1 Cellectics Details
2.4.2 Cellectics Major Business
2.4.3 Cellectics Genome Engineering Editing Product and Solutions
2.4.4 Cellectics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cellectics Recent Developments and Future Plans
2.5 CRISPR Therapeutics
2.5.1 CRISPR Therapeutics Details
2.5.2 CRISPR Therapeutics Major Business
2.5.3 CRISPR Therapeutics Genome Engineering Editing Product and Solutions
2.5.4 CRISPR Therapeutics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 CRISPR Therapeutics Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Genome Engineering Editing Product and Solutions
2.6.4 AstraZeneca Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 Bio Rad
2.7.1 Bio Rad Details
2.7.2 Bio Rad Major Business
2.7.3 Bio Rad Genome Engineering Editing Product and Solutions
2.7.4 Bio Rad Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Bio Rad Recent Developments and Future Plans
2.8 Allele Biotech
2.8.1 Allele Biotech Details
2.8.2 Allele Biotech Major Business
2.8.3 Allele Biotech Genome Engineering Editing Product and Solutions
2.8.4 Allele Biotech Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Allele Biotech Recent Developments and Future Plans
2.9 Recombinetics
2.9.1 Recombinetics Details
2.9.2 Recombinetics Major Business
2.9.3 Recombinetics Genome Engineering Editing Product and Solutions
2.9.4 Recombinetics Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Recombinetics Recent Developments and Future Plans
2.10 Lonza
2.10.1 Lonza Details
2.10.2 Lonza Major Business
2.10.3 Lonza Genome Engineering Editing Product and Solutions
2.10.4 Lonza Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Lonza Recent Developments and Future Plans
2.11 Illumina
2.11.1 Illumina Details
2.11.2 Illumina Major Business
2.11.3 Illumina Genome Engineering Editing Product and Solutions
2.11.4 Illumina Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Illumina Recent Developments and Future Plans
2.12 Editas Medicine
2.12.1 Editas Medicine Details
2.12.2 Editas Medicine Major Business
2.12.3 Editas Medicine Genome Engineering Editing Product and Solutions
2.12.4 Editas Medicine Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Editas Medicine Recent Developments and Future Plans
2.13 Agilent Technologies
2.13.1 Agilent Technologies Details
2.13.2 Agilent Technologies Major Business
2.13.3 Agilent Technologies Genome Engineering Editing Product and Solutions
2.13.4 Agilent Technologies Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Agilent Technologies Recent Developments and Future Plans
2.14 QIAGEN NV
2.14.1 QIAGEN NV Details
2.14.2 QIAGEN NV Major Business
2.14.3 QIAGEN NV Genome Engineering Editing Product and Solutions
2.14.4 QIAGEN NV Genome Engineering Editing Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 QIAGEN NV Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genome Engineering Editing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Genome Engineering Editing by Company Revenue
3.2.2 Top 3 Genome Engineering Editing Players Market Share in 2024
3.2.3 Top 6 Genome Engineering Editing Players Market Share in 2024
3.3 Genome Engineering Editing Market: Overall Company Footprint Analysis
3.3.1 Genome Engineering Editing Market: Region Footprint
3.3.2 Genome Engineering Editing Market: Company Product Type Footprint
3.3.3 Genome Engineering Editing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genome Engineering Editing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Genome Engineering Editing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genome Engineering Editing Consumption Value Market Share by Application (2020-2025)
5.2 Global Genome Engineering Editing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Genome Engineering Editing Consumption Value by Type (2020-2031)
6.2 North America Genome Engineering Editing Market Size by Application (2020-2031)
6.3 North America Genome Engineering Editing Market Size by Country
6.3.1 North America Genome Engineering Editing Consumption Value by Country (2020-2031)
6.3.2 United States Genome Engineering Editing Market Size and Forecast (2020-2031)
6.3.3 Canada Genome Engineering Editing Market Size and Forecast (2020-2031)
6.3.4 Mexico Genome Engineering Editing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Genome Engineering Editing Consumption Value by Type (2020-2031)
7.2 Europe Genome Engineering Editing Consumption Value by Application (2020-2031)
7.3 Europe Genome Engineering Editing Market Size by Country
7.3.1 Europe Genome Engineering Editing Consumption Value by Country (2020-2031)
7.3.2 Germany Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.3 France Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.5 Russia Genome Engineering Editing Market Size and Forecast (2020-2031)
7.3.6 Italy Genome Engineering Editing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genome Engineering Editing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Genome Engineering Editing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Genome Engineering Editing Market Size by Region
8.3.1 Asia-Pacific Genome Engineering Editing Consumption Value by Region (2020-2031)
8.3.2 China Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.3 Japan Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.4 South Korea Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.5 India Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Genome Engineering Editing Market Size and Forecast (2020-2031)
8.3.7 Australia Genome Engineering Editing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Genome Engineering Editing Consumption Value by Type (2020-2031)
9.2 South America Genome Engineering Editing Consumption Value by Application (2020-2031)
9.3 South America Genome Engineering Editing Market Size by Country
9.3.1 South America Genome Engineering Editing Consumption Value by Country (2020-2031)
9.3.2 Brazil Genome Engineering Editing Market Size and Forecast (2020-2031)
9.3.3 Argentina Genome Engineering Editing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genome Engineering Editing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Genome Engineering Editing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Genome Engineering Editing Market Size by Country
10.3.1 Middle East & Africa Genome Engineering Editing Consumption Value by Country (2020-2031)
10.3.2 Turkey Genome Engineering Editing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Genome Engineering Editing Market Size and Forecast (2020-2031)
10.3.4 UAE Genome Engineering Editing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Genome Engineering Editing Market Drivers
11.2 Genome Engineering Editing Market Restraints
11.3 Genome Engineering Editing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genome Engineering Editing Industry Chain
12.2 Genome Engineering Editing Upstream Analysis
12.3 Genome Engineering Editing Midstream Analysis
12.4 Genome Engineering Editing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OFTABLES
Table 1. Global Genome Engineering Editing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Genome Engineering Editing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Genome Engineering Editing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Genome Engineering Editing Consumption Value by Region (2026-2031) & (USD Million)
Table 5.ThermoFisher Scientific Company Information, Head Office, and Major Competitors
Table 6.ThermoFisher Scientific Major Business
Table 7.ThermoFisher Scientific Genome Engineering Editing Product and Solutions
Table 8.ThermoFisher Scientific Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9.ThermoFisher Scientific Recent Developments andFuture Plans
Table 10. SIGMA ALDRICH Company Information, Head Office, and Major Competitors
Table 11. SIGMA ALDRICH Major Business
Table 12. SIGMA ALDRICH Genome Engineering Editing Product and Solutions
Table 13. SIGMA ALDRICH Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. SIGMA ALDRICH Recent Developments andFuture Plans
Table 15. Dharmacon?Horizo??n Discovery? Company Information, Head Office, and Major Competitors
Table 16. Dharmacon?Horizo??n Discovery? Major Business
Table 17. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Product and Solutions
Table 18. Dharmacon?Horizo??n Discovery? Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Cellectics Company Information, Head Office, and Major Competitors
Table 20. Cellectics Major Business
Table 21. Cellectics Genome Engineering Editing Product and Solutions
Table 22. Cellectics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Cellectics Recent Developments andFuture Plans
Table 24. CRISPRTherapeutics Company Information, Head Office, and Major Competitors
Table 25. CRISPRTherapeutics Major Business
Table 26. CRISPRTherapeutics Genome Engineering Editing Product and Solutions
Table 27. CRISPRTherapeutics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. CRISPRTherapeutics Recent Developments andFuture Plans
Table 29. AstraZeneca Company Information, Head Office, and Major Competitors
Table 30. AstraZeneca Major Business
Table 31. AstraZeneca Genome Engineering Editing Product and Solutions
Table 32. AstraZeneca Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. AstraZeneca Recent Developments andFuture Plans
Table 34. Bio Rad Company Information, Head Office, and Major Competitors
Table 35. Bio Rad Major Business
Table 36. Bio Rad Genome Engineering Editing Product and Solutions
Table 37. Bio Rad Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Bio Rad Recent Developments andFuture Plans
Table 39. Allele Biotech Company Information, Head Office, and Major Competitors
Table 40. Allele Biotech Major Business
Table 41. Allele Biotech Genome Engineering Editing Product and Solutions
Table 42. Allele Biotech Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Allele Biotech Recent Developments andFuture Plans
Table 44. Recombinetics Company Information, Head Office, and Major Competitors
Table 45. Recombinetics Major Business
Table 46. Recombinetics Genome Engineering Editing Product and Solutions
Table 47. Recombinetics Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Recombinetics Recent Developments andFuture Plans
Table 49. Lonza Company Information, Head Office, and Major Competitors
Table 50. Lonza Major Business
Table 51. Lonza Genome Engineering Editing Product and Solutions
Table 52. Lonza Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Lonza Recent Developments andFuture Plans
Table 54. Illumina Company Information, Head Office, and Major Competitors
Table 55. Illumina Major Business
Table 56. Illumina Genome Engineering Editing Product and Solutions
Table 57. Illumina Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Illumina Recent Developments andFuture Plans
Table 59. Editas Medicine Company Information, Head Office, and Major Competitors
Table 60. Editas Medicine Major Business
Table 61. Editas Medicine Genome Engineering Editing Product and Solutions
Table 62. Editas Medicine Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Editas Medicine Recent Developments andFuture Plans
Table 64. AgilentTechnologies Company Information, Head Office, and Major Competitors
Table 65. AgilentTechnologies Major Business
Table 66. AgilentTechnologies Genome Engineering Editing Product and Solutions
Table 67. AgilentTechnologies Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. AgilentTechnologies Recent Developments andFuture Plans
Table 69. QIAGEN NV Company Information, Head Office, and Major Competitors
Table 70. QIAGEN NV Major Business
Table 71. QIAGEN NV Genome Engineering Editing Product and Solutions
Table 72. QIAGEN NV Genome Engineering Editing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. QIAGEN NV Recent Developments andFuture Plans
Table 74. Global Genome Engineering Editing Revenue (USD Million) by Players (2020-2025)
Table 75. Global Genome Engineering Editing Revenue Share by Players (2020-2025)
Table 76. Breakdown of Genome Engineering Editing by CompanyType (Tier 1,Tier 2, andTier 3)
Table 77. Market Position of Players in Genome Engineering Editing, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 78. Head Office of Key Genome Engineering Editing Players
Table 79. Genome Engineering Editing Market: Company ProductTypeFootprint
Table 80. Genome Engineering Editing Market: Company Product ApplicationFootprint
Table 81. Genome Engineering Editing New Market Entrants and Barriers to Market Entry
Table 82. Genome Engineering Editing Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Genome Engineering Editing Consumption Value (USD Million) byType (2020-2025)
Table 84. Global Genome Engineering Editing Consumption Value Share byType (2020-2025)
Table 85. Global Genome Engineering Editing Consumption ValueForecast byType (2026-2031)
Table 86. Global Genome Engineering Editing Consumption Value by Application (2020-2025)
Table 87. Global Genome Engineering Editing Consumption ValueForecast by Application (2026-2031)
Table 88. North America Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 89. North America Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 90. North America Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 95. Europe Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 96. Europe Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 101. Asia-Pacific Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 102. Asia-Pacific Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Genome Engineering Editing Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Genome Engineering Editing Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 107. South America Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 108. South America Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Genome Engineering Editing Consumption Value byType (2020-2025) & (USD Million)
Table 113. Middle East & Africa Genome Engineering Editing Consumption Value byType (2026-2031) & (USD Million)
Table 114. Middle East & Africa Genome Engineering Editing Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Genome Engineering Editing Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Genome Engineering Editing Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Genome Engineering Editing Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Genome Engineering Editing Upstream (Raw Materials)
Table 119. Global Genome Engineering EditingTypical Customers
LIST OFFIGURES
Figure 1. Genome Engineering Editing Picture
Figure 2. Global Genome Engineering Editing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Genome Engineering Editing Consumption Value Market Share byType in 2024
Figure 4. CRISPR RNP
Figure 5. CRISPR mRNA
Figure 6. CRISPR Virus Delivery
Figure 7. Others
Figure 8. Global Genome Engineering Editing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Genome Engineering Editing Consumption Value Market Share by Application in 2024
Figure 10. RUO Picture
Figure 11. GMP Picture
Figure 12. Global Genome Engineering Editing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Genome Engineering Editing Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Market Genome Engineering Editing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Genome Engineering Editing Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Genome Engineering Editing Consumption Value Market Share by Region in 2024
Figure 17. North America Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 22. CompanyThree Recent Developments andFuture Plans
Figure 23. Global Genome Engineering Editing Revenue Share by Players in 2024
Figure 24. Genome Engineering Editing Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 25. Market Share of Genome Engineering Editing by Player Revenue in 2024
Figure 26.Top 3 Genome Engineering Editing Players Market Share in 2024
Figure 27.Top 6 Genome Engineering Editing Players Market Share in 2024
Figure 28. Global Genome Engineering Editing Consumption Value Share byType (2020-2025)
Figure 29. Global Genome Engineering Editing Market ShareForecast byType (2026-2031)
Figure 30. Global Genome Engineering Editing Consumption Value Share by Application (2020-2025)
Figure 31. Global Genome Engineering Editing Market ShareForecast by Application (2026-2031)
Figure 32. North America Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 33. North America Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 39. Europe Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 42.France Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 47. Asia-Pacific Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Genome Engineering Editing Consumption Value Market Share by Region (2020-2031)
Figure 49. China Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 52. India Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 56. South America Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Genome Engineering Editing Consumption Value Market Share byType (2020-2031)
Figure 61. Middle East & Africa Genome Engineering Editing Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Genome Engineering Editing Consumption Value Market Share by Country (2020-2031)
Figure 63.Turkey Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Genome Engineering Editing Consumption Value (2020-2031) & (USD Million)
Figure 66. Genome Engineering Editing Market Drivers
Figure 67. Genome Engineering Editing Market Restraints
Figure 68. Genome Engineering Editing MarketTrends
Figure 69. PortersFiveForces Analysis
Figure 70. Genome Engineering Editing Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
